COMBI fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
CombiGene AB engages in the development of new treatment for neurological diseases. It focuses on the research of therapy for patients with epilepsy. The company was founded by Lars Thunberg, Merab Kokaia and David Woldbye in 1990 and is headquartered in Lidingoe, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
COMBI has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company